Phase Ii, Double-Blinded, Randomized Study of Enzastaurin Plus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer
AuthID
P-003-8W4
P-003-8W4
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service